PR Greipp
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 20
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 13
- Co-authors
- RA Kyle (17 shared papers)W. Michael O’Fallon (7 shared papers)RA Kyle (3 shared papers)JA Katzmann (6 shared papers)MA Gertz (8 shared papers)GW Dewald (2 shared papers)TE Witzig (4 shared papers)JA Lust (4 shared papers)
- Journals
- Blood (23 papers)Haematologica (2 papers)The Journal of Experimental Medicine (1 paper)Leukemia (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesIsrael
In The Last Decade
PR Greipp
33 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 72
- Hematology 1.6k
- Genetics 550
- Oncology 781
- Molecular Biology 1.5k
- Nephrology 136
Countries citing papers authored by PR Greipp
This map shows the geographic impact of PR Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PR Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PR Greipp more than expected).
Fields of papers citing papers by PR Greipp
This network shows the impact of papers produced by PR Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PR Greipp. The network helps show where PR Greipp may publish in the future.
Co-authors
The 25 scholars most cited alongside PR Greipp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 327 | |
| 2 | 1993 | 241 | |
| 3 | 1985 | 189 | |
| 4 | 1986 | 164 | |
| 5 | 1988 | 142 | |
| 6 | 1999 | 134 | |
| 7 | 1991 | 132 | |
| 8 | 1988 | 123 | |
| 9 | 1978 | 106 | |
| 10 | 1996 | 86 | |
| 11 | 1983 | 83 | |
| 12 | 1984 | 81 | |
| 13 | 1996 | 81 | |
| 14 | 2009 | 71 | |
| 15 | Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. | 1993 | 62 |
| 16 | Advances in the diagnosis and management of myeloma. | 1992 | 51 |
| 17 | 1989 | 36 | |
| 18 | 1987 | 25 | |
| 19 | 1976 | 24 | |
| 20 | 1986 | 23 |
About PR Greipp
PR Greipp is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Epidemiology, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Cancer Treatment and Pharmacology (7 papers), Neuroendocrine Tumor Research Advances (6 papers), Peptidase Inhibition and Analysis (5 papers), Parathyroid Disorders and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (550 citations), Oncology (781 citations), Molecular Biology (1.5k citations) and Nephrology (136 citations). PR Greipp has collaborated with scholars based in United States and Israel. Frequent co-authors include RA Kyle, W. Michael O’Fallon, RA Kyle, JA Katzmann, MA Gertz, GW Dewald, TE Witzig, JA Lust, Rafaël Fonseca and S. Vincent Rajkumar. Their work appears in journals such as Blood, Haematologica, The Journal of Experimental Medicine, Leukemia and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.